21-2024: AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. [RULE 36 JUDGMENT], NonprecedentialBy: Federal Circuiton February 15, 2022 at 4:00 pm Publication: U.S. Court of Appeals for the Federal CircuitLicensing, Litigation & Appeals Insights Downloadable Copy of Opinion>> Read More>>ShareTweetPinShare
